Acute Exacerbation of Idiopathic Pulmonary Fibrosis With Pirfenidone and Nintedanib: A Friend or Foe

Acute exacerbation (AE) in idiopathic pulmonary fibrosis (IPF) is unfortunate a deadly event with a very high mortality rate. Its occurrence is highly unpredictable, though few baseline risk factors have been identified. The revised definition of AE is more precise with clarity on defined parameters...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaushal, Mohit, Talwar, Dhruv, Prajapat, Deepak, Kumar, Sunil, Acharya, Sourya, Talwar, Deepak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957895/
https://www.ncbi.nlm.nih.gov/pubmed/35371648
http://dx.doi.org/10.7759/cureus.22606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957895/
https://www.ncbi.nlm.nih.gov/pubmed/35371648
http://dx.doi.org/10.7759/cureus.22606

Ejemplares similares